Evidence map›Paper›PMID 38011731›Full record

ArticleThe American journal of tropical medicine and hygiene2024

Schistosomiasis Seroprevalence among Children Aged 0-14 Years in Nigeria, 2018.

Anne Straily, Israel Tamunonengiyeofori, Ryan E Wiegand, Nnaemeka C Iriemenam, McPaul I Okoye, Ayuba B Dawurung, Nkechi Blessing Ugboaja, Martha Tongha, Nishanth Parameswaran, Stacie M Greby and 9 more

Open access · hybridAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Distribution of urinary schistosomiasis and associated risk factors among school-age children in Kwara State, Nigeria.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Anne StrailyDivision of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia.
Israel TamunonengiyeoforiNigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
Ryan E WiegandDivision of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia.
Nnaemeka C IriemenamDivision of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Nigeria.
McPaul I OkoyeDivision of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Nigeria.
Ayuba B DawurungInstitute of Human Virology, Abuja, Nigeria.
Nkechi Blessing UgboajaInstitute of Human Virology, Abuja, Nigeria.
Martha TonghaInstitute of Human Virology, Abuja, Nigeria.
Nishanth ParameswaranDivision of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia.
Stacie M GrebyDivision of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Nigeria.
Matthias AlagiDivision of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Nigeria.
Nseobong M AkpanNeglected Tropical Diseases, Federal Ministry of Health, Abuja, Nigeria.
William E NwachukwuNigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
Nwando MbaNigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
Diana L MartinDivision of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia.
W Evan SecorDivision of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia.
Mahesh SwaminathanDivision of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Nigeria.
Ifedayo AdetifaNigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
Chikwe IhekweazuNigeria Centre for Disease Control and Prevention, Abuja, Nigeria.
Nigeria Centre for Disease Control · NGCenters for Disease Control and Prevention · USInstitute of Human Virology · NGFederal Ministry of Health · NG

Funding

Gates Foundation INV-002096
6 · The paper itself

Abstract

The first nationally representative, population-based study of schistosomiasis seroprevalence in Nigeria was conducted using blood samples and risk-factor data collected during the 2018 Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS). Schistosomiasis seroprevalence was estimated by analyzing samples for reactivity to schistosome soluble egg antigen (SEA) in a multiplex bead assay; NAIIS survey data were assessed to identify potential risk factors for seropositivity. The SEA antibody data were available for 31,459 children aged 0 to 14 years. Overall seroprevalence was 17.2% (95% CI: 16.3-18.1%). Seropositive children were identified in every age group, including children < 5 years, and seroprevalence increased with increasing age (P < 0.0001). Several factors were associated with increased odds of seropositivity, including being a boy (odds ratio [OR] = 1.34, 95% CI: 1.24-1.45), living in a rural area (OR = 2.2, 95% CI: 1.9-2.5), and animal ownership (OR = 1.67, 95% CI: 1.52-1.85). Access to improved sanitation and drinking water sources were associated with decreased odds of seropositivity (OR = 0.52, 95% CI: 0.47-0.58 and OR = 0.53, 95% CI: 0.47-0.60, respectively) regardless of whether the child lived in a rural (sanitation: adjusted odds ratio [aOR] = 0.7, 95% CI: 0.6-0.8; drinking water: aOR = 0.7, 95% CI: 0.6-0.8) or urban area (sanitation: aOR = 0.6, 95% CI: 0.5-0.7; drinking water: aOR = 0.5, 95% CI: 0.4-0.6), highlighting the importance of these factors for schistosomiasis prevention and control. These results identified additional risk populations (children < 5 years) and a new risk factor (animal ownership) and could be used to monitor the impact of control programs.

Indexed as

Drinking WaterSchistosomiasisAnimalsChildHumansMaleNigeriaRisk FactorsSchistosomaSeroepidemiologic StudiesDrinking Water

Identifiers

PMID38011731
PMCPMC10793028
OpenAlexW4389044491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.